A review of the clinical effects of phytoestrogens

Obstetrics and Gynecology

Volumn 87, Issue 5 PART 2, 1996, Pages 897-904

  Knight, David C ^a   Eden, John A ^a  

^a Royal Hospital for Women   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PHYTOESTROGEN;

CANCER INHIBITION; CANCER PREVENTION; CHOLESTEROL METABOLISM; CORONARY ARTERY DISEASE; DATA ANALYSIS; DIETARY INTAKE; DRUG EFFECT; DRUG EFFICACY; ESTROGEN METABOLISM; HUMAN; MEDICAL INFORMATION; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW; VEGETABLE;

ANIMALS; CARDIOVASCULAR DISEASES; CLIMACTERIC; DIET; ESTROGENS, NON-STEROIDAL; FEMALE; HUMANS; ISOFLAVONES; LIGNANS; NEOPLASMS; OSTEOPOROSIS, POSTMENOPAUSAL; PHYTOESTROGENS; PLANT PREPARATIONS; PLANTS; SOYBEANS; TUMOR CELLS, CULTURED;

EID: 0029960272     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Western diet and Western diseases: Some hormonal and biochemical mechanisms and associations
2. Cancers of the breast, endometrium and ovary: Geographic correlations
3. Climacteric and menopause in seven south-east Asian countries
4. Reproductive and general metabolic effects of phytoestrogens in mammals
5. Soya—A dietary source of the non-steroidal estrogen equol in man and animals
6. Mammalian lignan production from various foods
7. Naturally occurring estrogens in foods—A review
8. Mammalian lignans and phytooestrogens. Recent studies on their formation, metabolism and biological role in health and disease
9. Lignans in man and animal species
10. Identification and quantitative estimation of a lignan in human and bovine semen
11. The excretion of lignans in rats—Evidence for an intestinal bacterial source for this new group of compounds
12. Urinary lignan and isoflavonoid excretion in premenopausal women consuming flaxseed powder.
13. Origin of lignans in mammals and identification of a precursor from plants
14. Determination of lignans and isoflavonoids in plasma by isotope dilution gas chromatography-mass spectrometry.
15. Determination of urinary lignans and phytoestrogen metabolites, potential antiestrogens and anticarcinogens, in urine of women on various habitual diets
16. Identification of isoflavonic phyto-oestrogens and of lignans in human urine and in cow's milk by GC/MS
17. Effect of dietary components, including lignans and phytoestrogens, on enterohepatic circulation and liver metabolism of estrogens and on sex hormone binding globulin (SHBG)
18. Non-steroidal estrogens of dietary origin: Possible roles in hormone dependent disease
19. The variable metabolic response to dietary isoflavones in humans
20. Soybean isoflavones: Effect of environment and variety on composition
21. Determination of isoflavones in soybean flours, protein concentrates and isolates
22. Tofu and soy drinks contain phytoestrogens
23. Isoflavone content in commercial soybean foods
24. Diet, breast cancer and sex hormone metabolism
25. The antiviral action of lignans
26. Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1
27. Soybean isoflavones. Characterization, determination, and antifungal activity
28. Antibacterial Activity of Selected Isoflavonoids
29. Inhibition of in vitro microsomal lipid peroxidation by isoflavonoids
30. Antimutagens and anticarcinogens: A survey of putative interceptor molecules
31. Flavones. 3. Synthesis, biological activities, and conformational analysis of isoflavone derivatives and related compounds
32. Antiproliferative activity of synthetic and naturally occurring flavonoids on tumour cells of the human breast carcinoma cell line, ZR-75-1
33. In vitro bioassays of non-steroidal phytoestrogens
34. Soy intake and cancer risk: A review of the in vitro and in vivo data
35. Phytoestrogen interaction with estrogen receptors in human breast cancer cells
36. Genistein, a specific inhibitor of tyrosine-specific protein kinases.
37. Effect of genistein on topoisomerase activity and on the growth of [val12]Ha-ras-transformed NIH 3T3 cells
38. Mechanisms of action in NIH-3T3 cells of genistein, an inhibitor of EGF receptor tyrosine kinase activity
39. Genistein, a dietary-derived inhibitor of in vitro angiogenesis
40. Genistein as an inducer of tumor cell differentiation: Possible mechanisms of action
41. Inhibition of tumour promoter-induced hydrogen peroxide formation in vitro and in vivo by genistein
42. Antixoidant and antipromotional effects of the soybean isoflavone genistein
43. Oncogenes and signal transduction
44. The natural tyrosine kinase inhibitor genistein produces cell cycle arrest and apoptosis in Jurkat T-leukaemia cells
45. Identification of phosphotyrosine as a product of epidermal growth factor-activated protein kinase in A-431 cell membranes
46. Platelet-derived growth factor stimulates tyrosine-specific protein kinase activity in Swiss mouse 3T3 cells membranes
47. Insulin activates a tyrosine-specific protein kinase in extracts of 3T3-L1 adipocytes and human placenta.
48. Stimulation of tyrosine-specific phosphorylation in vitro by insulin-like growth factor I
49. A novel mechanism for the induction of aromatase in ovarian cells in vitro: Role of transforming growth factor alpha-induced protein tyrosine kinase
50. Genistein inhibition of the growth of human breast cancer cells: Independence from estrogen receptors and the multi-drug resistance gene
51. Neu differentiation factor: A transmembrane glycoprotein containing an EGF domain and an immunoglobulin homology unit
52. Food legumes in human nutrition: A personal perspective
53. Phytoestrogen influences on the development of behaviour and gonadotropin function
54. Neonatal genistein chemoprevents mammary cancer
55. Prolactin synthesis by cultured rat pituitary cells: An assay to study estrogens, antiestrogens and their metabolites in vitro
56. Biological effects of estrogens and antiestrogens in the fetus and newborn
57. A twin study of polycystic ovary syndrome
58. A specific breeding problem of sheep on subterranean clover pastures in western Australia
59. Dietary intervention study to assess estrogenicity of dietary soy among postmenopausal women
60. The polycystic ovary syndrome—A review
61. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis
62. Hip fractures in the elderly: A world-wide projection
63. Calcium supplementation of the diet: Not justified by present evidence
64. Effects of 1-year treatment with ipriflavone on bone in postmenopausal women with low bone mass
65. Ipriflavone prevents the bone mass reduction in premenopausal women treated with gonadotropin hormone-releasing hormone agonists
66. Flavonoids: biochemical effects and therapeutic applications
67. Mastering the menopause
68. A study of menopause in Malaysia
69. The climacteric of Chinese factory workers
70. Oestrogenic effects of plant foods in postmenopausal women
71. The vaginal epithelium in the postmenopause—cytology, histology and pH as methods of assessment
72. Comparative Trial of P1496, a New Non-steroidal Oestrogen Analogue
73. International comparison of mortality rates for cancer of the breast, ovary, prostate, and colon, per capita fat consumption
74. Variability in diet and its relation to risk in ethnic and migrant groups
75. Dietary effects on breast cancer risk in Singapore
76. Biological effects of a diet of soy protein rich in isoflavones on the menstrual cycle of premenopausal women.
77. Genistein, daidzein, and their .beta.-glycoside conjugates: antitumor isoflavones in soybean foods from American and Asian diets
78. A rationale for dietary intervention in postmenopausal breast cancer patients: An update
79. Breast cancer in women of Japanese and Caucasian ancestry in Hawaii
80. The effect of dietary fat on breast cancer survival among Caucasian and Japanese women in Hawaii
81. Excretion of the lignans enterolactone and enteroidol and of equol in omnivorous and vegetarian women and in women with breast cancer
82. Estradiol and progesterone receptors in malignant gastrointestinal tumours
83. The effects of steroid hormones on a human colon cancer cell line in vitro
84. Antiproliferative effects of isoflavones on human cancer cell lines established from the gastrointestinal tract
85. Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiological evidence
86. Review of clinical studies on cholesterol-lowering response to soy protein
87. Meta-analysis of the effects of soy protein intake on serum lipids
88. Effects of hormone replacement therapy on lipoprotein (a) levels and lipids in postmenopausal women
89. Tamoxifen and estrogen lower circulating lipoprotein(a) concentrations in healthy postmenopausal women